Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Procyanidins from grape seeds reduce nerve pain by blocking specific proteins and inflammation.

Human placenta hydrolysate may help treat COVID-19 by reducing virus replication and boosting immune response.

Oral minoxidil improves hair growth in men with hair loss, but caution needed for those with heart issues.

Most doctors know the thrombosis risk with Cyproterone/Ethinylestradiol, but some lack details on less common risks and patient instructions; educational materials are underused but useful.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

The XBB lineage of the Omicron variant spread rapidly in Southeastern Wisconsin.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

A new compound shows promise as a topical treatment for hair loss.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

EGCG shows strong electron transfer interactions when bonded to DPPG lipids.

More symptoms during initial COVID infection increase the risk of long-term effects.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Metformin may help mild COVID-19 cases, while Oseltamivir, Tamoxifen, and Dexamethasone are suggested for severe cases.

Bimatoprost 0.03% is as effective as minoxidil 2% for eyebrow growth.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

Non-drug methods like diet, supplements, and aromatherapy can help manage hair loss and its emotional impact.

Compound 7p shows strong potential as an anticancer agent.

The essential oils nanoemulsion promotes hair growth better than 2% minoxidil in mice.

Certain patient characteristics can help predict hair regrowth success with ritlecitinib in alopecia areata.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Urban children in western Belarus had more severe COVID-19 cases in 2021.

Patients with deficiency syndrome, especially qi deficiency, have a higher risk of type 2 heart attacks.

Systemic minoxidil might help maintain hair regrowth in alopecia areata.

Sodium valproate caused vomiting, hair loss, loss of appetite, abdominal pain, weight gain, and anemia in young children with epilepsy.

Minoxidil with caffeine works better for hair loss than minoxidil alone.

The study identified and characterized new keratin genes linked to hair follicles and epithelial tissues.